Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47 |
filingDate |
2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2020503900-A |
titleOfInvention |
Recombinant alpha-galactosidase A for the treatment of Fabry disease |
abstract |
Compositions comprising α-galactosidase A enzymes having unique carbohydrate profiles and methods for making and purifying such enzymes are described. Methods for treating, preventing, and / or alleviating Fabry disease by administering such enzymes to a subject in need thereof are also described. Compositions comprising migrastat in combination with such α-galactosidase A enzymes have also been described. [Selection diagram] FIG. |
priorityDate |
2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |